The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription
Domingo, Christian ![ORCID Identifier](/img/uab/orcid.ico)
(Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Singh, Dave ![ORCID Identifier](/img/uab/orcid.ico)
(Manchester University National Health Service Foundation Trust)
Universitat Autònoma de Barcelona
Date: |
2023 |
Abstract: |
Short-acting β agonists (SABAs) have been a mainstay of asthma treatment since the 1950s, and have been mainly recommended as-needed for symptom relief alongside daily inhaled corticosteroid (ICS)-based maintenance treatment for the past 30 years. However, patient adherence to regular ICS-based anti-inflammatory maintenance therapy is frequently poor, leading to SABA overuse for symptom relief and associated poor outcomes. At present, there is a lack of consensus between treatment guidelines on how SABA should be used, and as-needed ICS-formoterol is suggested by some as an alternative reliever therapy. Here, we examine the pharmacology and current use of inhaled SABAs, identify that regular dosing of ICS can encourage appropriate SABA use, and appraise the evidence used to support the changing reliever treatment recommendations. We conclude that SABA continues to play an important role in the asthma management landscape, and give our views on how it should be used in patients with mild-moderate asthma, to complement regular ICS-based maintenance treatment. |
Rights: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. ![Creative Commons](/img/licenses/by-nc.ico) |
Language: |
Anglès |
Document: |
Article ; recerca ; Versió publicada |
Subject: |
Asthma ;
GINA ;
Guidelines ;
Recommendations ;
SABA ;
Salbutamol ;
Treatment |
Published in: |
Advances in Therapy, Vol. 40 (january 2023) , p. 1301-1316, ISSN 1865-8652 |
DOI: 10.1007/s12325-022-02410-z
PMID: 36715896
The record appears in these collections:
Research literature >
UAB research groups literature >
Research Centres and Groups (research output) >
Health sciences and biosciences >
Parc Taulí Research and Innovation Institute (I3PTArticles >
Research articlesArticles >
Published articles
Record created 2023-07-27, last modified 2024-06-11